The BRCA2-EMSY connection: implications for breast and ovarian tumorigenesis.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 14651841.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this issue, Hughes-Davies et al. describe a novel gene product, EMSY, which suppresses the transactivational activity of BRCA2. EMSY is located within an amplicon in sporadic breast and ovarian cancers, suggesting that its overexpression may mimic the effects of BRCA2 inactivation. The implications for BRCA2 function are discussed.
Medical subject headings
- BRCA2 Protein
- Breast Neoplasms
- Carcinoma
- Ovarian Neoplasms
- Tumor Suppressor Proteins